Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission

• Leo Yi Yang Lee ,

  Contributed equally to this work with: Leo Yi Yang Lee, Jie Zhou

  Roles Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation WHO Collaborating Centre for Reference and Research on Influenza, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia

  http://orcid.org/0000-0001-6704-1235

  ⨯
• Jie Zhou ,

  Contributed equally to this work with: Leo Yi Yang Lee, Jie Zhou

  Roles Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Department of Infectious Disease, Imperial College London, London, United Kingdom

  ⨯
• Rebecca Frise,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliation Department of Infectious Disease, Imperial College London, London, United Kingdom

  http://orcid.org/0000-0002-5522-623X

  ⨯
• Daniel H. Goldhill,

  Roles Formal analysis, Methodology, Writing – review & editing

  Affiliation Department of Infectious Disease, Imperial College London, London, United Kingdom

  http://orcid.org/0000-0003-4597-5963

  ⨯
• Paulina Koszalka,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliations WHO Collaborating Centre for Reference and Research on Influenza, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia, Biomedicine Discovery Institute & Department of Microbiology, Monash University, Victoria 3800, Australia

  http://orcid.org/0000-0002-8346-1624

  ⨯
• Edin J. Mifsud,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliations WHO Collaborating Centre for Reference and Research on Influenza, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia, Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Parkville, Australia

  ⨯
• Kaoru Baba,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliation Shionogi TechnoAdvance Research, Co., Ltd., Osaka, Japan

  ⨯
• Takahiro Noda,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliation Shionogi TechnoAdvance Research, Co., Ltd., Osaka, Japan

  ⨯
• Yoshinori Ando,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliation Shionogi & Co., Ltd, Osaka, Japan

  ⨯
• Kenji Sato,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliation Shionogi & Co., Ltd, Osaka, Japan

  ⨯
• Aoe-Ishikawa Yuki,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliation Shionogi TechnoAdvance Research, Co., Ltd., Osaka, Japan

  ⨯
• Takao Shishido,

  Roles Methodology, Writing – review & editing

  Affiliation Shionogi & Co., Ltd, Osaka, Japan

  ⨯
• Takeki Uehara,

  Roles Writing – review & editing

  Affiliation Shionogi & Co., Ltd, Osaka, Japan

  ⨯
• Steffen Wildum,

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  Affiliation F. Hoffmann-La Roche Ltd, Basel, Switzerland

  http://orcid.org/0000-0001-9779-5740

  ⨯
• Elke Zwanziger,

  Roles Investigation, Methodology, Writing – review & editing

  Affiliation F. Hoffmann-La Roche Ltd, Basel, Switzerland

  ⨯
• Neil Collinson,

  Roles Conceptualization, Funding acquisition, Writing – review & editing

  Affiliation Roche Products Ltd, Welwyn, United Kingdom

  ⨯
• Klaus Kuhlbusch,

  Roles Conceptualization, Writing – review & editing

  Affiliation F. Hoffmann-La Roche Ltd, Basel, Switzerland

  ⨯
• Barry Clinch,

  Roles Conceptualization, Writing – review & editing

  Affiliation Roche Products Ltd, Welwyn, United Kingdom

  ⨯
• Aeron C. Hurt ,

  Roles Conceptualization, Methodology, Writing – original draft, Writing – review & editing

  * E-mail: aeron.hurt@roche.com (ACH); w.barclay@imperial.ac.uk (WSB)

  ¶‡ These authors are joint senior authors on this work.

  Affiliations WHO Collaborating Centre for Reference and Research on Influenza, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia, Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Parkville, Australia, F. Hoffmann-La Roche Ltd, Basel, Switzerland

  ⨯
•  [ ... ],
• Wendy S. Barclay

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  * E-mail: aeron.hurt@roche.com (ACH); w.barclay@imperial.ac.uk (WSB)

  ¶‡ These authors are joint senior authors on this work.

  Affiliation Department of Infectious Disease, Imperial College London, London, United Kingdom

  http://orcid.org/0000-0002-3948-0895

  ⨯
• [ view all ]
• [ view less ]